Abstracts from 27th Congress of the European College of Neuropsychopharmacology (ECNP): An in vitro, in vivo, in silico approach to investigate effects of OAT3 inhibition on bumetanide levels in the brain

Maria Donovan; Fionn  O'Brien; Geraldine Boylan; Brendan Griffin; J.F.  Cryan

Abstracts from 27th Congress of the European College of Neuropsychopharmacology (ECNP): An in vitro, in vivo, in silico approach to investigate effects of OAT3 inhibition on bumetanide levels in the brain

Research output: Contribution to journal › Meeting abstract › peer-review

Original language	English (Ireland)
Journal	European Neuropsychopharmacology
Volume	24
Issue number	S2
Publication status	Published - Oct 2014

Cite this

@article{867af43eaa1c4798802997e220f409a6,

title = "Abstracts from 27th Congress of the European College of Neuropsychopharmacology (ECNP): An in vitro, in vivo, in silico approach to investigate effects of OAT3 inhibition on bumetanide levels in the brain ",

author = "Maria Donovan and Fionn O'Brien and Geraldine Boylan and Brendan Griffin and J.F. Cryan",

year = "2014",

month = oct,

language = "English (Ireland)",

volume = "24",

journal = "European Neuropsychopharmacology",

issn = "0924-977X",

publisher = "Elsevier B.V.",

number = "S2",

}

Abstracts from 27th Congress of the European College of Neuropsychopharmacology (ECNP): An in vitro, in vivo, in silico approach to investigate effects of OAT3 inhibition on bumetanide levels in the brain . / Donovan, Maria; O'Brien, Fionn ; Boylan, Geraldine et al.
In: European Neuropsychopharmacology, Vol. 24, No. S2, 10.2014.

Research output: Contribution to journal › Meeting abstract › peer-review

TY - JOUR

T1 - Abstracts from 27th Congress of the European College of Neuropsychopharmacology (ECNP)

T2 - An in vitro, in vivo, in silico approach to investigate effects of OAT3 inhibition on bumetanide levels in the brain

AU - Donovan, Maria

AU - O'Brien, Fionn

AU - Boylan, Geraldine

AU - Griffin, Brendan

AU - Cryan, J.F.

PY - 2014/10

Y1 - 2014/10

M3 - Meeting abstract

SN - 0924-977X

VL - 24

JO - European Neuropsychopharmacology

JF - European Neuropsychopharmacology

IS - S2

ER -